Please Wait
Applying Filters...
28 Mar 2024
// PRESS RELEASE
24 Jan 2024
// PRESS RELEASE
23 Nov 2023
// PHARMACEUTICAL-TECHNOLOGY
Data Compilation
#PharmaFlow
01 2FENOFIBRATE
02 1ISOSORBIDE MONONITRATE
01 1TABLET, EXTENDED RELEASE;ORAL
02 2TABLET;ORAL
01 1160MG
02 150MG
03 160MG
01 2DISCN
02 1RX
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : TRIGLIDE
Dosage Strength : 50MG
Approval Date : 2005-05-07
Application Number : 21350
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code : BX
Dosage Form : TABLET; ORAL
Proprietary Name : TRIGLIDE
Dosage Strength : 160MG
Approval Date : 2005-05-07
Application Number : 21350
RX/OTC/DISCN : RX
RLD : Yes
TE Code : BX
RLD : No
TE Code :
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Proprietary Name : ISOSORBIDE MONONITRATE
Dosage Strength : 60MG
Approval Date : 1999-10-07
Application Number : 75166
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
LOOKING FOR A SUPPLIER?
Market Place
KEY SERVICES
Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.
